Amplification at 12q13-14 in human malignant gliomas is frequently accompanied by loss of heterozygosity at loci proximal and distal to the amplification site.
We have recently reported that a subset of human malignant gliomas shows amplification and overexpression of multiple genes from chromosomal segment 12q13-14, including CDK4, SAS, and MDM2. In the present study we have performed an allelotyping for 16 polymorphic loci spanning both arms of chromosome 12 in a series of 136 gliomas. Allelic deletions were found in 50% (7 of 14) of the malignant gliomas with 12q13-14 amplification and involved loci located on 12q proximal and distal to the amplification site. In contrast, the incidence of allelic loss on chromosome 12 was significantly lower in gliomas without 12q13-14 amplification [14% (11 of 79) in the WHO grade III and IV gliomas, 9% (4 of 43) in the WHO grade I and II gliomas]. The frequent association between 12q13-14 amplification and loss of alleles from 12q is in line with a model suggesting chromosome breakage and deletion as important events in the development of gene amplification.
Department of Pathology, Sahlgrenska Hospital, Gothenburg, Sweden.
G
G
Reifenberger
J
J
Reifenberger
K
K
Ichimura
V P
VP
Collins
D000483:Alleles; D001254:Astrocytoma / Q000235:genetics; D002881:Chromosomes, Human, Pair 12; D005784:Gene Amplification; D017353:Gene Deletion; D005909:Glioblastoma / Q000235:genetics; D005910:Glioma / Q000235:genetics*; D006579:Heterozygote; D006801:Humans